Europe — EMA

Odomzo (Sonidegib)

Request sourcing

Pack/s

What is Sonidegib?

Sonidegib, the active ingredient in Odomzo, is a targeted therapy presented as a capsule for oral use. It treats locally advanced basal cell carcinoma in patients who are not candidates for surgery or radiation. GNH USA supplies Odomzo as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres worldwide.

GNH USA supplies Odomzo as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres worldwide.

What is Sonidegib used for?

Odomzo is ...

What are the side effects of Sonidegib?

Common

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →

Product details

Drug

Sonidegib

Route

Oral Use

Manufacturer

Sun Pharmaceutical Industries Europe B.V.

Origin